{"blog": [], "keywords": [{"value": "American College of Cardiology", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "JOURNAL OF THE AMERICAN MEDICAL ASSN", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Heart", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Cholesterol", "name": "subject", "rank": "5", "is_major": "Y"}, {"value": "Stroke", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "Preventive Medicine", "name": "subject", "rank": "7", "is_major": "N"}, {"value": "Eli Lilly and Company", "name": "organizations", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/04/04/health/dashing-hopes-study-shows-cholesterol-drug-has-no-benefits.html", "document_type": "article", "byline": {"person": [{"lastname": "KOLATA", "firstname": "Gina", "role": "reported", "organization": "", "rank": 1}], "original": "By GINA KOLATA"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/04/04/us/04heart-web/04heart-web-thumbWide.jpg", "legacy": {"wide": "images/2016/04/04/us/04heart-web/04heart-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/04/04/us/04heart-web/04heart-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/04/us/04heart-web/04heart-web-articleLarge.jpg", "xlargeheight": "899", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 899}, {"url": "images/2016/04/04/us/04heart-web/04heart-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/04/us/04heart-web/04heart-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Health", "word_count": "1212", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Experts were stunned by a study of 12,000 patients that showed the drug, evacetrapib, had no effect in preventing heart attacks, strokes or death from heart disease.", "pub_date": "2016-04-04T00:00:00Z", "news_desk": "National", "headline": {"print_headline": "Dashing Hopes, Study Shows a Cholesterol Drug Had No Effect on Heart Health ", "main": "Dashing Hopes, Study Shows a Cholesterol Drug Had No Effect on Heart Health"}, "print_page": "11", "snippet": "Experts were stunned by a study of 12,000 patients that showed the drug, evacetrapib, had no effect in preventing heart attacks, strokes or death from heart disease.", "_id": "5701b7d538f0d81980921994", "slideshow_credits": null, "abstract": "American College of Cardiology announces study published online in JAMA unexpectedly finding that promising drug evacetrapib is ineffective in fighting heart disease; potential alternative to statins, which reduced LDL cholesterol and boosted HDL cholesterol, did not produce cardiac benefits researchers expected."}